Literature DB >> 16678464

Medically attended pediatric influenza during the resurgence of the Victoria lineage of influenza B virus.

Ladonna K Hite1, W Paul Glezen, Gail J Demmler, Flor M Munoz.   

Abstract

OBJECTIVES: During the 2002-2003 season, a new variant of influenza B co-circulated with influenza A viruses. This study examines the characteristics and outcomes of children with influenza A and B virus infection vs. other acute respiratory illnesses.
METHODS: A retrospective chart review was performed on children with laboratory-confirmed influenza infection, and influenza negative acute respiratory illnesses that prompted a hospital visit.
RESULTS: Children with influenza were more often previously healthy and presenting with upper respiratory symptoms, while influenza negative patients typically had underlying medical conditions, and lower respiratory tract disease. Children with influenza B were older, were more likely to be in school, and presented with myositis more frequently than those with influenza A. A third of children with influenza A, and 42% with influenza B required hospitalization. The highest hospitalization rates were in infants under one year. No healthy children, and only 15% of those with chronic medical problems, had received influenza vaccine. Vaccine efficacy was estimated to be 82.6%.
CONCLUSIONS: Most children with influenza were previously healthy. Overall, a third of children with influenza required hospitalization. Influenza A and B were clinically indistinguishable, except for older age and higher incidence of myositis in patients with influenza B. Influenza vaccine coverage in both healthy and high-risk children was low.

Entities:  

Mesh:

Year:  2006        PMID: 16678464     DOI: 10.1016/j.ijid.2005.10.008

Source DB:  PubMed          Journal:  Int J Infect Dis        ISSN: 1201-9712            Impact factor:   3.623


  33 in total

1.  Transmission of influenza B viruses in the guinea pig.

Authors:  Natalie Pica; Yi-Ying Chou; Nicole M Bouvier; Peter Palese
Journal:  J Virol       Date:  2012-02-01       Impact factor: 5.103

2.  [The universal influenza vaccination in children with Vaxigrip Tetra® in Italy: an evaluation of Health Technology Assessment].

Authors:  Sara Boccalini; Angela Bechini; Maddalena Innocenti; Gino Sartor; Federico Manzi; Paolo Bonanni; Donatella Panatto; Piero Luigi Lai; Francesca Zangrillo; Emanuela Rizzitelli; Mariasilvia Iovine; Daniela Amicizia; Chiara Bini; Andrea Marcellusi; Francesco Saverio Mennini; Alessandro Rinaldi; Francesca Trippi; Anna Maria Ferriero; Giovanni Checcucci Lisi
Journal:  J Prev Med Hyg       Date:  2018-05-30

Review 3.  The burden of influenza B: a structured literature review.

Authors:  W Paul Glezen; Jordana K Schmier; Carrie M Kuehn; Kellie J Ryan; John Oxford
Journal:  Am J Public Health       Date:  2013-01-17       Impact factor: 9.308

4.  Cost-effectiveness analysis of universal influenza vaccination with quadrivalent inactivated vaccine in the United States.

Authors:  Karen M Clements; Genevieve Meier; Lisa J McGarry; Narin Pruttivarasin; Derek A Misurski
Journal:  Hum Vaccin Immunother       Date:  2014-03-07       Impact factor: 3.452

5.  The coming era of quadrivalent human influenza vaccines: who will benefit?

Authors:  Ian G Barr; Lauren L Jelley
Journal:  Drugs       Date:  2012-12-03       Impact factor: 9.546

6.  Seroprevalence of influenza A and B in German infants and adolescents.

Authors:  Andreas Sauerbrei; R Schmidt-Ott; H Hoyer; P Wutzler
Journal:  Med Microbiol Immunol       Date:  2009-02-05       Impact factor: 3.402

7.  Population-Based Pediatric Hospitalization Burden of Lineage-Specific Influenza B in Hong Kong, 2004-2014.

Authors:  Benjamin J Cowling; Peng Wu; Janice Y C Lo; Kwok-Hung Chan; Eunice L Y Chan; Vicky J Fang; Lok-Yee So; J S Malik Peiris; Susan S Chiu
Journal:  Clin Infect Dis       Date:  2017-07-15       Impact factor: 9.079

8.  Clinical and socioeconomic impact of different types and subtypes of seasonal influenza viruses in children during influenza seasons 2007/2008 and 2008/2009.

Authors:  Susanna Esposito; Claudio Giuseppe Molteni; Cristina Daleno; Antonia Valzano; Emilio Fossali; Liviana Da Dalt; Valerio Cecinati; Eugenia Bruzzese; Raffaella Giacchino; Carlo Giaquinto; Angie Lackenby; Nicola Principi
Journal:  BMC Infect Dis       Date:  2011-10-12       Impact factor: 3.090

Review 9.  The rationale for quadrivalent influenza vaccines.

Authors:  Christopher S Ambrose; Myron J Levin
Journal:  Hum Vaccin Immunother       Date:  2012-01-01       Impact factor: 3.452

10.  A randomized trial of candidate inactivated quadrivalent influenza vaccine versus trivalent influenza vaccines in children aged 3-17 years.

Authors:  Joseph B Domachowske; Heidemarie Pankow-Culot; Milagros Bautista; Yang Feng; Carine Claeys; Mathieu Peeters; Bruce L Innis; Varsha Jain
Journal:  J Infect Dis       Date:  2013-03-07       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.